Abstract
BackgroundQuality of cancer care (QoCC) has become an important item for providers, regulators and purchasers of care worldwide. Aim of this study is to present the results of some evidence-based quality indicators (QI) for prostate cancer (PC) at the population-based level and to compare the outcomes with data available in the literature.MethodsThe study included all PC diagnosed on a three years period analysis (01.01.2011–31.12.2013) in the population of Canton Ticino (Southern Switzerland) extracted from the Ticino Cancer Registry database. 13 QI, approved through the validated Delphi methodology, were calculated using the “available case” approach: 2 for diagnosis, 4 for pathology, 6 for treatment and 1 for outcome. The selection of the computed QI was based on the availability of medical documentation. QI are presented as proportion (%) with the corresponding 95% confidence interval.Results700 PC were detected during the three-year period 2011–2013: 78.3% of them were diagnosed through a prostatic biopsy and for 72.5% 8 or more biopsy cores were taken. 46.5% of the low risk PC patients underwent active surveillance, while 69.2% of high risk PC underwent a radical treatment (radical prostatectomy, radiotherapy or brachytherapy) and 73.5% of patients with metastatic PC were treated with hormonal therapy. The overall 30-day postoperative mortality was 0.5%.ConclusionsResults emerging from this study on the QoCC for PC in Canton Ticino are encouraging: the choice of treatment modalities seems to respect the international guidelines and our results are comparable to the scarce number of available international studies. Additional national and international standardisation of the QI and further QI population-based studies are needed in order to get a real picture of the PC diagnostic-therapeutic process progress through the definition of thresholds of minimal standard of care.
Highlights
Quality of cancer care (QoCC) has become an important item for providers, regulators and purchasers of care worldwide
Results emerging from this study on the QoCC for prostate cancer (PC) in Canton Ticino are encouraging: the choice of treatment modalities seems to respect the international guidelines and our results are comparable to the scarce number of available international studies
Additional national and international standardisation of the quality indicators (QI) and further QI population-based studies are needed in order to get a real picture of the PC diagnostic-therapeutic process progress through the definition of thresholds of minimal standard of care
Summary
Quality of cancer care (QoCC) has become an important item for providers, regulators and purchasers of care worldwide. In Switzerland, about 6200 PC cases are diagnosed annually, representing 30% of all tumours diagnoses. With a European age-standardized incidence rate of 158.6 cases per 100′000 inhabitants, the Switzerland is one of the countries with the highest incidence in Europe [1, 2]. The. Since the late ‘90s, in addition to survival analysis, studies about the Quality of Cancer Care (QoCC) became increasingly important to providers, regulators and purchasers of care worldwide as they strive to systematically measure and improve care [3]. QoCC studies performed using data of cancer registries evaluate and compare the quality of care at the population-based level giving a real description of the pattern of care at the regional level, without selection bias.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
